Carbon Monoxide

Carbon Monoxide

SCHEMBL9988779

Cl[Re].[C]=O.[C]=O.[C]=O.c1ccc(SCCSc2ccccc2)cc1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.71
MAPK1 P28482 1/20 0.71
FFAR1 O14842 1/20 0.46
RAB9A P51151 5/20 0.46
NPC1 O15118 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
CYP1A2 P05177 3/20 0.46
CYP2D6 P10635 3/20 0.46
CYP2C19 P33261 3/20 0.46
CYP3A4 P08684 2/20 0.46
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
RECQL P46063 1/20 0.44
CYP2C9 P11712 1/20 0.44
HIF1A Q16665 1/20 0.44
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbon Monoxide SCHEMBL9987491 0.91 ALDH1A1 (0.58) ALDH1A1MAPK1FFAR1RAB9ANPC1
Formaldehyde SCHEMBL14837510 0.85 ALDH1A1 (0.62) ALDH1A1MAPK1FFAR1RAB9ANPC1
SCHEMBL776647 0.84 ALDH1A1 (1.00) ALDH1A1MAPK1FFAR1RAB9ANPC1
SCHEMBL95987 0.75 ALDH1A1 (0.70) ALDH1A1MAPK1FFAR1RAB9ANPC1
SCHEMBL123612 0.75 ALDH1A1 (0.70) ALDH1A1MAPK1FFAR1RAB9ANPC1
SCHEMBL1931125 0.74 ALDH1A1 (0.78) ALDH1A1MAPK1FFAR1RAB9ANPC1
SCHEMBL420011 0.74 ALDH1A1 (0.78) ALDH1A1MAPK1FFAR1RAB9ANPC1
SCHEMBL5143403 0.73 ALDH1A1 (0.75) ALDH1A1MAPK1FFAR1RAB9ANPC1
SCHEMBL5169003 0.72 ALDH1A1 (0.74) ALDH1A1MAPK1FFAR1RAB9ANPC1
SCHEMBL5167895 0.72 ALDH1A1 (0.74) ALDH1A1MAPK1FFAR1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987491-B2 Rhenium complexes and their pharmaceutical use SOCIETE DE COORDINATION DE RECHERCHES THERAPEUTIQUES (FR) 2015-03-24 US disclosed
EP-2575800-B1 RHENIUM COMPLEXES AND THEIR PHARMACEUTICAL USE. COORDINATION DE RECH S THERAPEUTIQUES SOC D (FR) 2015-01-14 EP disclosed
US-20130158109-A1 RHENIUM COMPLEXES AND THEIR PHARMACEUTICAL USE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-06-20 US disclosed
EP-2392324-A1 Rhenium complexes and their pharmaceutical use SOCIETE DE COORDINATION DE RECHERCHES THERAPEUTIQUES (FR) 2011-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158109-A1 RHENIUM COMPLEXES AND THEIR PHARMACEUTICAL USE REN, PKD1, KRAS ALDH1A1 3976/4885MAPK1 1478/4885FFAR1 4595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.